Amelogenesis imperfecta (AI) represents a broad spectrum of genetic diseases aecting enamel formation in both the primary and permanent dentitions. AI has been classi®ed into 14 dierent subtypes according to the clinical appearance of the enamel and the Mendelian mode of inheritance (1) . The combined prevalence of all forms of AI has been reported as 1:14,000 in the US (1), 1:8,000 in Israel (2), 1:4,000 in Sweden (3) and 1:700 in the VaÈ sterbotten county of Sweden (4) . The enamel abnormalities have been categorized into three major groups, hypocalci®ed, hypomaturation, or hypoplastic, and the inheritance patterns reported include autosomal dominant or recessive, and X-linked dominant or recessive (1) .
The autosomal dominant forms of AI are the most prevalent forms, representing over 95% of all reported cases and have been shown to be genetically heterogeneic (5) . To date, a disease locus has been established for only one type of autosomal dominant AI, the local hypoplastic form (AIH2). AIH2 was initially mapped in three Swedish families to human chromosome 4q11±q21 within a 17.6 cM region (6) . This locus was further re®ned to a 4-Mb region located between D4S2421 and the albumin gene by recombination breakpoint mapping using six Swedish families (7) .
Ameloblastin (Ambn; also known as amelin and sheathlin) was initially isolated as the most abundant novel transcript from 400 random rat incisor cDNAs (8) . The clone was 1925 bp, and contained multiple putative open reading frames (ORFs) with the longest encoded a 422 amino acid acidic protein with a reported pI of 5.54 and an M r of 45 kDa. Using a similar approach, other investigators independently cloned two rat transcripts, termed amelin 1 and 2, which code for the same protein (9) . In situ hybridization studies have shown Ambn to be expressed at high levels by the enamel-producing ameloblast cells (8±11) with Amelogenesis imperfecta is a broad classi®cation of hereditary enamel defects, exhibiting both genetic and clinical diversity. Most amelogenesis imperfecta cases are autosomal dominant disorders, yet only the local hypoplastic form has been mapped to human chromosome 4q between D4S2421 and the albumin gene. An enamel protein cDNA, termed ameloblastin (also known as amelin and sheathlin), has been isolated from rat, mouse and pig. Its human homolog has been mapped to chromosome 4q21 between markers D4S409 and D4S400,¯anking the local hypoplastic amelogenesis imperfecta critical region. Therefore, ameloblastin is a strong candidate gene for this form of amelogenesis imperfecta. To facilitate genetic studies related to this dental disease, we isolated and characterized a human ameloblastin cDNA. A human third molar cDNA library was screened and two ameloblastin clones identi®ed. Nucleotide sequencing of these cDNAs indicated alternative splicing of the putative open reading frame, use of dierent polyadenylation signals, and a high degree of similarity to reported rat, mouse and porcine cDNAs. Immunohistochemistry studies on embryonic human teeth using an antibody to recombinant ameloblastin indicated ameloblastin expression by ameloblasts with localization in the enamel matrix associated with the sheath structures. (12, 13) and transient expression by preodontoblasts (13) . Immunohistochemistry has demonstrated localization to the ameloblast cell layer, with intense staining in the distal cytoplasm of ameloblasts, the Tomes processes of secretory ameloblasts, and within the matrix at the dentinoenamel junction (DEJ) (8, 10, 13±15) with limited expression in early preodontoblasts (13) . Rat and mouse Ambn cDNAs (8, 9, 16) showed homology with the sequence of a 15-kDa enamel matrix sheath protein (14) identi®ed by biochemical analysis of enamel matrix, as well as the corresponding porcine cDNA termed sheathlin (17) . The mouse Ambn locus has been mapped to chromosome 5, distal to the Kit gene (8) . More precise mapping of the human AMBN locus using two-color¯uorescence in situ hybridization has placed the gene on the long arm of human chromosome 4, between the sequence tagged site (STS) markers D4S400 and D4S409 (18) . This region, 4q13±q21, has been shown to contain the gene locus for AIH2 (7) . Furthermore, a human AMBN genomic P1 arti®cial chromosome (PAC) clone was shown to contain three STS markers, D4S2604, D4S2670 and D4S2609, previously placed within the critical AIH2 region as de®ned by haplotyping using six Swedish families (18) . Therefore, AMBN appears to be a strong candidate gene for this form of AI.
Mary
To determine the genomic organization of human AMBN and thereby facilitate genetic studies related to AIH2, we have isolated and characterized human Ambn cDNA clones. In addition, the spatial expression pattern of the translated protein during early human tooth development has been analyzed.
Material and methods

Labeled Ambn probe
The rat Ambn cDNA (1.9 kb) (8) was labeled to a high speci®c activity using the Prime-It II random priming kit (Stratagene, La Jolla, CA, USA) and [a-32 P]dCTP. The probe was puri®ed using a Sephadex G-50 column as previously described (16) .
Human tooth cDNA library screening
A previously characterized human third molar cDNA library (19) was plated with host cell XL1-Blue MRF' at a density of 5610 4 plaques per 150-mm LB plate. Plaques were transferred to duplicate nylon ®lters, denatured, neutralized and rinsed as previously described (19) . Damp ®lters were ultraviolet (UV)-cross-linked (Stratalinker; Stratagene) using the auto setting, rinsed in distilled water, and prehybridized for 2 h at 68³C in Quik-Hyb hybridization solution (Stratagene) plus 100 mg/ml of sheared salmon sperm DNA.
Filters were hybridized with labeled rat Ambn as previously described (16) . Blotted ®lters were placed on Biomax MR-1 ®lm (Kodak, Rochester, NY, USA) overnight at À70³C with intensifying screens. Putative positive clones (*25 plaques) were selected and con®rmed by polymerase chain reaction (PCR) ampli®cation with an Ambn-speci®c primer set as previously described (16) . Samples which were positive for Ambn amplicons were plated at a density of approximately 100 plaques/ 100 mm plate and a secondary screen performed as described above using a mouse full length Ambn cDNA probe (16) . Six tertiary screened plaques were picked, and tested for insert length using PCR with¯anking vector-speci®c primers generated to the T3 and T7 RNA polymerase promoter sequences. These clones were rescued to Bluescript SK(À) phagemids using the Ex-assist Helper Phage kit (Stratagene).
DNA sequence and analysis DNA sequence was determined using automated sequencing (Applied Biosystems, Model 370A) at the Human Genome DNA Core Laboratory (University of Texas Health Science Center, San Antonio, TX, USA). Unresolved DNA sequence was determined manually using Sequenase 2.0 kit according to the suppliers instructions (Amersham USB, Arlington Heights, IL, USA). A contiguous DNA sequence was generated using the Assemblylign program (Kodak) using data from multiple overlapping sequence reactions. Open reading frame, protein subsequence, and amino acid content were analyzed using MacVector 6.0 (Oxford Molecular, Campbell, CA, USA). Protein alignments were generated using the Clustal W (1.4) feature of MacVector 6.0 using default program settings. Isoelectric points, and isotope averaged molecular weight were calculated using MacBiospec (Perkin-Elmer Sciex, Thornhill, Ontario, Canada).
Immunohistochemistry
Mandibles from fetuses (n~4; 21±26 wk of gestation) were obtained after pathological diagnosis for medical reasons, with parental informed signed consent. This study was performed on a limited collection under the approved direction of the French National Ethics committee. Samples were ®xed in buered formaldehyde, decalci®cation with nitric acid (Labonor, Paris, France), dehydrated, paran-embedded and histological sections (5 mm) prepared. Primary and secondary antibodies, as well as conjugated peroxidase, were diluted in a solution of 0.05 M Tris NaCl, pH 7.6 containing 1% normal goat serum (NGS; Amersham, les Ulis, France). Washes were performed in 0.05% Tris NaCl solution, pH 7.6, containing 1% bovine serum albumin (Sigma, le Verpilliere, France). Endogenous peroxidases in the tissues were inactivated by treatment with 3% H 2 O 2 for 15 min. The tissue was then blocked with 10% NGS for 24 h at 4³C. The primary antibody (1:5,000 dilution) was incubated for 18 h at 4³C, biotinylated secondary antibody (1:800, Sigma) for 30 min, and streptavidin peroxidase (1:300, Vector, Paris, France) for 30 min. Diaminobenzidine was used as the peroxidase substrate (Sigma). The sections were counterstained with Harris hematoxylin (Shandon, Paris, France), dehydrated and mounted. Micrographs were taken with a Zeiss Orthoplan microscope.
Results
In order to facilitate determination of AMBN gene structure and mutational analysis for AIH2, we screened a human third molar cDNA library using full-length rat and mouse Ambn cDNA clones. Initial screening of approximately 5610 4 recombinants resulted in 25 primary clones. Small aliquots of these primary isolates were initially con®rmed by PCR ampli®cation using an Ambn primer set based rat cDNA sequence (rAmbnY274S 5'AGATTCCACTTTTCAAAATG3' and rAmbn-Y274AS 5'TTCTGGGGTGTGACCCTG3'). Positive isolates were then subjected to a single secondary screening at low density using radiolabeled full-length mouse Ambn cDNA clone (16) . Isolated positive single clones were again ampli®ed by PCR using vector-speci®c primers to the insert anking T3 and T7 RNA polymerase promoter segments of the Bluescript SKzvector¯anking the insert in order to determine the approximate cDNA insert size. Six clones containing the largest inserts were chosen for further DNA sequence analysis. These human Ambn clones were rescued to phagemid, and the DNA sequence of both strands determined. The longest clone (human 1A2) was 1983 bp exclusive of the poly A tail, and contained an open reading frame encoding 447 amino acids (Genebank accession number AF209780). This clone contained a long untranslated 3' region with three potential polyadenylation signals (AATAAA) (Fig. 1) . The putative start site (ATG) was at base 84, with a potential signal peptide of 26 amino acids. Selection of this initial methionine (Met) as the start codon was based on previously published rat and mouse Ambn sequences (8, 16) . Additional clones identi®ed varied by the inclusion or exclusion of a 45-bp segment encoding 15 amino acids (98±112) and the length of the 3' untranslated region (arrow, Fig. 1 ) by the use of the second or third polyadenylation signals beginning at nucleotides 1615 or 1963, respectively. The 15-amino acid (45-bp) segment YEYSLPVHPPPLPSLQ of the human Ambn clone was 100% conserved with a segment shown to be alternately spliced at the mRNA level in rat and mouse Ambn and in pig sheathlin (8, 4, 17) . This segment contained 8.0% of the total proline residues found in the mature human protein.
Alignment of the predicted amino acid sequence for human Ambn with published sequences for pig, mouse and rat cDNA clones is shown in Fig. 2 . This data indicates that Ambn is a highly conserved protein between the four species studied. The human Ambn amino acid sequences was more similar to that of the pig sheathlin than the two reported rodent clones. Between human and pig, we found 65% identity with an additional 9% conservative substitution. The unique ®ve-amino acid deletion (AQGMA) found in pig sheathlin beginning at amino acid 35 is also absent in the human Ambn clone, as well as a single proline after amino acid 165. In addition, three single amino acid insertions of glycine (aa 322), phenalanine (aa 408), and glutamic acid (aa 436), and one two-amino acid insert of lysine±glycine (aa 371±372) are found in the human Ambn sequence. These insertions are again more similar to the sequence of pig sheathlin. Most interesting is the insertion of 26 amino acids found unique to the human AMBN cDNA that is not contained in any other species. This segment SLPGMDFPDPQGPSLPGLDFADPQGS) contains an almost perfect double repeat of a 13 amino acid sequence (amino acids 190±215, underlined). The potential post-translational modi®cation of human Ambn by casein kinase II at residue 262 is conserved, as is the tyrosine kinase site at residue 98.
The predicted mature human protein would have a calculated isotope-averaged molecular weight of 45.6 kDa and would be weakly acidic with a pI of 6.1. Molecular weight, pI, and amino acid content of human Ambn is similar to rat, mouse and porcine proteins (Table 1) . Human protein is rich in proline (15%), glycine (9%), alanine (7.6%), and leucine (9.7%), with no cysteine found as previously reported for other species.
Immunolocalization studies were performed using a previously characterized Ambn antibody generated against a recombinant rat COOH region protein (aa 175±348) and therefore able to recognize both isoforms (8) . This antibody has been tested for speci®city by Western blot using recombinant Ambn protein, extracts of various tissues and enamel extracellular matrix (Y. Yamada, unpublished data). At the prenatal stages examined, Ambn protein was only evident by immunocytochemistry within developing tooth organs. Ambn immunoreactivity ®rst appeared in the secretion stage ameloblasts. Inside the cell compartment, Ambn epitopes were exclusively located inside large, rounded structures at the distal end of the cell body. Extracellularly, immunoreactive enamel was present nearby the secretory pole of ameloblasts and also in the vicinity of the dentinal-enamel junction. In the deep layers of forming enamel, immunoreactivity varied, the prism sheaths were associated with highest apparent concentrations with diused staining between these structures. Faint immunostaining was also present in the predentin region and within the developing odontoblast cell layer facing mantle dentin. However, staining was not detectable within forming bone, Meckels cartilage, buccal epithelium, muscles, or salivary glands.
Discussion
We have identi®ed six human Ambn cDNA clones, exhibiting alternative splicing and the use of two dierent polyadenylation signals. Analysis of the isolated clone showed there was no direct correlation with the inclusion or exclusion of the 45-bp (15 aa) alternatively spliced segment with utilization of a particular polyadenylation signal. The two alternatively spliced transcripts we report agree with the Northern blot ®ndings of two rat Ambn transcripts (1.6 and 2.0 kb) (8) . The amino acid content of high proline (15%), glycine (10%), alanine (9%), and leucine (9%) for human Ambn Fig. 3 . Immunolocalization of Ambn in a pre-natal human developing tooth germ at 26 weeks. Positive immunoperoxidase staining using a 1:5000 dilution of the anti-ameloblastin antibody is shown in panels 1 (406), 2 (1006) and 4 (1006). No staining was seen using a 1:5000 dilution of control IgGs (panel 3, 1006) . Ambn immunoreactivity appears located intracellularly within the distal part of the ameloblast cell body (panels 1 and 2). Extracellularly, positive labeling is seen within the newly forming enamel next to the ameloblasts and distally at the enamel dentinal junction. Notably, light, sporadic staining of the distal ends of the dentinal tubules could be seen (panel 1). At high magni®cation (1006), within the ameloblasts staining appeared associated with distal secretory granules (panel 2, long arrows). In the extracellular matrix, a more intense staining was found at the prism borders referred to as``enamel sheaths'', while lighter more diuse staining was observed in the remainder of the enamel matrix. Abbreviations: a, ameloblasts; e, enamel; d, dentin; o, odontoblasts; s, sheaths; and p, prisms.
remains consistent with that found in other species (8, 4, 16) as does the calculated pI of 6.1.
The presence of two alternatively spliced transcripts of human Ambn is comparable to that reported for mouse Ambn (16) and pig sheathlin sequence (17) . The alternatively spliced 45-bp segment, amino acid sequence YEYSLPVHPPP-LPSQ, is 100% conserved in all species studied to date. This homology across vertebrate evolution suggests a signi®cant functional role for this segment during amelogenesis. The presence of a unique 5 amino acid insert in mouse and rat Ambn is also absent in human as reported for pig (17) . Most interesting is the 26 amino acid insertion found exclusively in the human Ambn sequence. Most likely, this segment arose through the insertion and duplication of a smaller 13 amino acid sequence based on the degree of amino acid similarity. This segment increases the molecular weight of both human Ambn isoforms, as well as increasing the overall acidity of the human protein.
One of the slight ambiguities related to the Ambn cDNA clones identi®ed to date is the assignment of the start codon between the ®rst, second or third Met. The ®rst Met is the start codon (*90% of eukaryotic mRNAs), and this initial codon is preceded by a purine (adenine or guanine) in the (À3) position (*97% of eukaryotic sequences) (20) . This leads to a con¯ict for all reported Ambn sequences, where the ®rst Met does not have a purine at the À3 position. This would support the assignment of the second Met as the start codon which does have an adenine in the correct position, leading to a shorter 16 amino acid signal peptide. However, at the amino acid level the sequence between the ®rst and second Met is highly conserved (8 out of 10 residues) between species, suggesting utilization of the ®rst Met.
The present investigation demonstrates immunological cross-reactivity between a polyclonal recombinant rat Ambn antibody and native human Ambn epitopes. This evidence supports the existence of homologies in these polypeptide regions between both species. Previously, studies have shown this same cross-reactivity on human forming tooth germs at the early bell stage of development (10) . In contrast to the early expression of Ambn mRNAs at E-14 by RT-PCR analysis (16), the protein was only detectable in dierentiated ameloblasts. However, the detection of early protein synthesis may be under the threshold of immunohistochemistry sensitivity, since decalci®cation procedures may delete more than 50% of the immunoreactive species (21) , and human samples are not ideally preserved in contrast to experimental approaches using animal models where intracardiac perfusions are usually performed (10, 14, 21, 22) . Comparative data on the cellular and extracellular distribution of Ambn (human, the present study and rat incisor; 8, 22, 23) shows conservation among mammals for the respective compartmentalization of matrix proteins during the process of enamel formation. In our study, immunoreactivity for Ambn proteins appeared concentrated in the prism sheaths of forming enamel, as shown previously for the NH 2 -terminal region of rat Ambn (22) and porcine sheathlin (14) . However, the distribution of immunoreactive species at the secretory pole of ameloblasts was not related to the formation of enamel sheath as also seen in rat (22, 23) , but in contrast to localization in pig (14) . The present data support the notion that Ambn may constitute a functional group of proteins which contribute to the formation of prism sheaths.
The characterization of the Ambn cDNA sequence will facilitate determination of the genomic organization of the gene and future mutational analyses in patients presenting with the local hypoplastic form of AI.
